BioLabs

🧬 Calling biotech innovators in Canada: your next breakthrough could start here. Apply to the AbbVie Biotech Innovators Award for a chance to win a complementary lab space at BioLabs University of Toronto along with access to a mentorship program, both awards sponsored by our founding Sponsor AbbVie Bring your science closer to impact with the space, resources, and guidance to accelerate your journey. 📅 Application Deadline: November 10 🔗 To learn more and to apply visit: https://lnkd.in/gusNfbc2 AbbVie | Canada | BioLabs University of Toronto | BioLabs | Life Sciences Ontario | Allison Brown | Christina Vorvis, PhD | Christian R. Schubert | Johannes Fruehauf | Susan Chase

BioLabs will be at BioJapan 2026 in Yokohama next week! From 7 to 9 October, our team will be at PACIFICO Yokohama for BioJapan's 40th edition. The event brings together pharma, biotech, investors and academic groups from across Asia and beyond. We're going to meet founders, partners and industry teams interested in growing their science across borders. We'd also like to share how BioLabs supports early-stage life science companies, from lab space to programmes and partnerships. If you're attending, come say hello at booth C-67 or send us a message to set up a meeting. 📍 PACIFICO Yokohama 📅 7–9 October 2026 #BioJapan2026 #LifeSciences #Biotech #Startups #Yokohama

And Munich now has a BioLabs. Another site in our global network, on the same model as everywhere else: fully equipped labs, shared equipment and industry expertise, available to a founder from day one. The ribbon came down on Monday. Our founder and CEO Johannes Fruehauf opened. Philipp Gerbert, CEO of TUM Venture Labs, set out how TUM Venture Labs backs founders across technology verticals, and now, with us, in biotech. Judith Gerlach, Member of the Bundesrat, told the room that Bavaria's startup scene is "Chefsache". Floris Engelhardt, founder of Kano Therapeutics and one of our residents, described running a company on two continents through BioLabs | TUM and LabCentral. Our Munich site director Max Pöhlmann opened the doors. Tours through the afternoon. Dr. Dr. Radhika Patnala's science art in the lobby. The building was the visible part. The work it exists for starts quietly, at a bench, and takes years. None of this happens without our partners. Thank you to Thermo Fisher Scientific, Eppendorf, MilliporeSigma, PROTEROS biostructures GmbH, Elemental Machines, Corning Life Sciences, Sartorius, Promega Corporation, New England Biolabs, Nikon and AbbVie for making this site possible. 🙏 Thank you to our speakers, to TUM Venture Labs, and to everyone who came. We look forward to the science and the partnerships that will grow from here. Johannes Fruehauf Johanna Michielin Max Pöhlmann Ornella Mehlhorn

🎟️ Golden Ticket opportunities are OPEN at two different BioLabs Sites in North America ! Early-stage biotech startups can apply for one year of BioLabs membership and lab space, plus valuable industry connections and mentorship. BioLabs Rochester MN 📅 Deadline: October 20, 2026 Apply for a chance to Join the brand new BioLabs site in Rochester 🔗 Apply today https://lnkd.in/gsXbBTE4 BioLabs University of Toronto- The Abbvie Biotech Innovators Award, hosted by the Site's Founding Sponsor AbbVie 📅 Deadline: November 10, 2026 🔗 Apply here: https://lnkd.in/gusNfbc2 🚀 Ready to take your science to the next level? 👉 Explore ongoing Golden ticket opportunities by visiting our Golden Ticket webpage: https://lnkd.in/eb9Sy-CQ

Applications are now open !! BioLabs University of Toronto is excited to partner with founding sponsor, AbbVie, to support the next generation of biotechnology innovators in Ontario with the AbbVie Biotech Innovators Award. The award provides up to two companies with one year of laboratory and office space at BioLabs University of Toronto at no cost, including access to shared equipment, support and mentorship. Eligible Canada-based biotechnology companies with the potential to develop transformative therapies in areas aligned with AbbVie’s focus, including #immunology, #oncology, #neuroscience and, #aesthetics are invited to apply. The application deadline is November 10, 2026. Learn more and apply: https://lnkd.in/gusNfbc2 Read the full press release: EN: https://lnkd.in/gHrwx3WU FR: https://lnkd.in/gDxyG3-8 AbbVie | Canada| BioLabs University of Toronto | BioLabs | Life Sciences Ontario

If you are a start up looking for lab space in the Rochester area in Minnesota, then this Golden ticket is for you. Apply to this program for a chance to win a free lab space at the brand new BioLabs Rochester MN. Application deadline is October 20th but don't wait, APPLY TODAY https://lnkd.in/gsXbBTE4

Calling all biotech startups in Japan! There are only a few days left to apply for Investor Day Japan Fall 2026, taking place on November 11 in Tokyo! Selected companies will have the opportunity to pitch directly to venture capital firms, receive live investor feedback, connect with global investors and industry leaders, and showcase their innovations to members of the international life sciences ecosystem. 📅 Applications close September 17, 2026 (JST). If you��re an early-stage biotech company looking to gain investor exposure and build global connections, we encourage you to apply! 👉 Apply here: https://lnkd.in/gP9hRuPu #BioLabs #InvestorDay #JapanBiotech #Biotech #LifeSciences #Startups #VentureCapital

170 people from science, business, politics and the startup scene came to Forum Wissen in Göttingen last Friday for the launch of Startup Factory GOe FUTURE. If you haven't come across it yet: GOᵉ FUTURE is one of only ten Startup Factories in Germany, picked by the Federal Ministry for Economic Affairs and Energy and EXIST to turn research into companies. And a good look at how fast the life science scene around Göttingen, Hannover and Braunschweig is moving right now. What struck us was how clearly they've thought it through. Five programs, GOᵉ2LIFE, GOᵉ2IMPACT, GOᵉ2CONNECT, GOᵉ2SCALE and GOᵉ2CAPITAL, one for every step a researcher takes from a first idea to raising capital. Anyone who's watched a founder get stuck between those steps knows how rarely someone builds for all of them. And the room matched it. Federal and state government, founders, academics and industry, all in the same conversation about the same future. Congratulations to the whole GOᵉ FUTURE team. Thank you for having us. Johanna Michielin | Hélène Sire, PharmD l Michelle Bobbert | Elisabeth Zeisberg l Petra Runge-Wollmann |  Linda Ehm | Johann-Jesko Lange | Giulia Trovato

"Great collaborations don’t happen by accident, they’re built together. In this episode of b.empowered, recorded live at BIO 2026 in San Diego last June, our CEO and Founder, Johannes Fruehauf, sat down with Tiffani Manolis, Vice President and General Manager, Cell Biology at Thermo Fisher Scientific, to discuss what it takes to move advanced therapies innovation forward. Together, they explored BioLabs for Advanced Therapeutics Philadelphia, a joint initiative with Thermofisher Scientific, sharing the vision behind the site, what that collaboration looks like in practice, and their outlook on the future of advanced therapies. If you’re building — or supporting — the next generation of cell and gene therapy companies, this conversation is for you. 🔗 Watch the full episode here: https://lnkd.in/g6kHZx5h Give it a watch and let us know what you think 👇"